Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | Pyridone 6 |
Synonyms | |
Therapy Description |
Pyridone 6 (CMP6) is an ATP-competitive inhibitor of JAK1, 2, 3 and TYK2, which inhibits growth of cancer cells (PMID: 17018630). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
Pyridone 6 | CMP6 | JAK Inhibitor (Pan) - ATP competitive 3 | Pyridone 6 (CMP6) is an ATP-competitive inhibitor of JAK1, 2, 3 and TYK2, which inhibits growth of cancer cells (PMID: 17018630). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|---|---|---|---|---|---|---|
CSF3R S783fs | chronic neutrophilic leukemia | predicted - resistant | Pyridone 6 | Preclinical - Patient cell culture | Actionable | In a preclinical study, cells derived from a patient with chronic neutrophilic leukemia harboring CSF3R S783fs did not respond to treatment with Pyridone 6 (CMP6) in culture (PMID: 23656643). | 23656643 |
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|